公司资料
ANI Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- ANIP
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
76.00 USD (-0.71%)
收盘价
最后更新: 2026年8月17日
1.7B USD
市值
股价为何变动
As of Aug 17, 2026, ANIP closed down 0.71% at $76.00. No new same-company headline was identified in the current news window.
公司概览
Rare-Disease and Specialty Pharmaceuticals
ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines.
Cortrophin Gel
Purified Cortrophin Gel is an adrenocorticotropic hormone therapy used across selected autoimmune and inflammatory indications. It is the primary growth driver of ANI's rare-disease franchise.
Ophthalmology Portfolio
ILUVIEN and YUTIQ are sustained-release fluocinolone implants for retinal diseases, including diabetic macular edema and chronic noninfectious uveitis affecting the posterior segment.
未来催化剂
- Phase 4 SYNCHRONICITY results in noninfectious uveitis at a medical conference in the third quarter of 2026.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。